Holen Sie sich die Stockscreener-App
3.17
2.46%
-0.08
Handel nachbörslich:
3.22
0.05
+1.58%
Schlusskurs vom Vortag:
$3.25
Offen:
$3.21
24-Stunden-Volumen:
60,588
Relative Volume:
0.34
Marktkapitalisierung:
$66.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-94.11M
KGV:
-0.5275
EPS:
-6.01
Netto-Cashflow:
$-86.06M
1W Leistung:
+4.62%
1M Leistung:
+26.29%
6M Leistung:
-25.41%
1J Leistung:
-53.18%
1-Tages-Spanne:
$3.13
$3.30
1-Wochen-Bereich:
$2.9297
$3.30
52-Wochen-Spanne:
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
Firmenname
Adverum Biotechnologies Inc
Sektor
Branche
Telefon
(650) 649-1004
Adresse
100 CARDINAL WAY, REDWOOD CITY, CA
Vergleichen Sie ADVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
3.17 | 63.79M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-07 | Hochstufung | Truist | Hold → Buy |
| 2021-07-23 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | Herabstufung | Truist | Buy → Hold |
| 2020-12-16 | Eingeleitet | UBS | Neutral |
| 2020-11-12 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-05-05 | Hochstufung | SunTrust | Hold → Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-16 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-10 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Neutral |
| 2019-09-13 | Bestätigt | Chardan Capital Markets | Neutral |
| 2019-06-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-11-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | Herabstufung | SunTrust | Buy → Hold |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-08-30 | Eingeleitet | SunTrust | Buy |
| 2018-02-15 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-10-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Adverum Biotechnologies Inc Aktie (ADVM) Neueste Nachrichten
Does Adverum Biotechnologies Inc. stock benefit from AI growthJuly 2025 News Drivers & Expert Approved Trade Ideas - khodrobank.com
Risk adjusted return profile for Adverum Biotechnologies Inc. analyzed2025 Breakouts & Breakdowns & Community Shared Stock Ideas - Newser
Will earnings trigger a reversal in Adverum Biotechnologies Inc.Weekly Stock Summary & High Accuracy Investment Entry Signals - Newser
What dividend growth rate does Adverum Biotechnologies Inc. offerJuly 2025 Gainers & Reliable Price Action Trade Plans - khodrobank.com
What’s the analyst consensus on Adverum Biotechnologies Inc.Trade Ideas & High Conviction Buy Zone Picks - khodrobank.com
Trading Recap: Is Adverum Biotechnologies Inc. forming a breakout patternEarnings Growth Report & Weekly Breakout Opportunity Watchlist - khodrobank.com
Will Adverum Biotechnologies Inc. benefit from AI trendsPortfolio Gains Summary & Safe Swing Trade Setups - khodrobank.com
How to use a screener to detect Adverum Biotechnologies Inc. breakouts2025 Market Overview & Fast Moving Stock Watchlists - Newser
Applying Wyckoff theory to Adverum Biotechnologies Inc. stockWeekly Gains Summary & Weekly Watchlist for Consistent Profits - Newser
Real time breakdown of Adverum Biotechnologies Inc. stock performanceWeekly Trade Report & AI Powered Buy/Sell Recommendations - Newser
Using Bollinger Bands to evaluate Adverum Biotechnologies Inc.Fed Meeting & Daily Market Momentum Tracking - Newser
Key metrics from Adverum Biotechnologies Inc.’s quarterly dataJuly 2025 Summary & Real-Time Market Sentiment Reports - Newser
What is the long term forecast for Adverum Biotechnologies Inc. stockWeekly Trend Summary & Precise Swing Trade Alerts - khodrobank.com
Will Adverum Biotechnologies Inc. benefit from macro trends2025 Valuation Update & Precise Buy Zone Identification - Newser
Historical volatility pattern of Adverum Biotechnologies Inc. visualized2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Sentiment analysis tools applied to Adverum Biotechnologies Inc.July 2025 Momentum & AI Powered Market Trend Analysis - Newser
Is a relief rally coming for Adverum Biotechnologies Inc. holdersJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - Newser
Is Adverum Biotechnologies Inc. likely to announce a buybackJuly 2025 Closing Moves & Weekly High Conviction Trade Ideas - khodrobank.com
Is Adverum Biotechnologies Inc. showing insider buyingMarket Sentiment Report & Precise Trade Entry Recommendations - khodrobank.com
Is Adverum Biotechnologies Inc. stock bottoming outEarnings Miss & Expert Verified Movement Alerts - Newser
Will Adverum Biotechnologies Inc. benefit from current market trendsJuly 2025 Selloffs & Daily Entry Point Trade Alerts - khodrobank.com
Detecting support and resistance levels for Adverum Biotechnologies Inc.Portfolio Risk Summary & Entry and Exit Point Strategies - Newser
How to interpret RSI for Adverum Biotechnologies Inc. stockForecast Cut & Precise Buy Zone Identification - Newser
Adverum Biotechnologies Inc. stock prediction for this week2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - Newser
Ranking Adverum Biotechnologies Inc. among high performing stocks via toolsEntry Point & Safe Entry Zone Tips - Newser
Heatmap analysis for Adverum Biotechnologies Inc. and competitorsWeekly Stock Report & Risk Controlled Swing Alerts - Newser
Is Adverum Biotechnologies Inc. forming a bottoming baseMarket Activity Report & High Accuracy Buy Signal Tips - Newser
Does Adverum Biotechnologies Inc. show high probability of reboundJuly 2025 Opening Moves & Fast Moving Trade Plans - Newser
Will Adverum Biotechnologies Inc. rebound enough to break evenWeekly Stock Summary & AI Powered Market Entry Ideas - Newser
Technical analysis overview for Adverum Biotechnologies Inc. stockJuly 2025 Snapshot & Daily Profit Focused Screening - Newser
Finanzdaten der Adverum Biotechnologies Inc-Aktie (ADVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adverum Biotechnologies Inc-Aktie (ADVM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER |
May 15 '25 |
Sale |
2.00 |
924 |
1,848 |
13,768 |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR |
May 15 '25 |
Sale |
2.00 |
9,126 |
18,252 |
87,488 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 27 '25 |
Buy |
5.19 |
16,593 |
86,089 |
141,800 |
| Leonard Braden Michael | 10% Owner |
Apr 22 '25 |
Buy |
3.00 |
300,000 |
900,000 |
3,057,526 |
| Leonard Braden Michael | 10% Owner |
Apr 23 '25 |
Buy |
2.98 |
50,000 |
148,950 |
191,800 |
| Leonard Braden Michael | 10% Owner |
Mar 31 '25 |
Buy |
4.38 |
19,566 |
85,668 |
2,742,317 |
| Leonard Braden Michael | 10% Owner |
Apr 02 '25 |
Buy |
4.04 |
15,209 |
61,408 |
2,757,526 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 18 '25 |
Buy |
4.69 |
62,341 |
292,418 |
2,667,161 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):